Fairmount Funds Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,336,368
| Closed | -$28.8M | – | 21 |
|
|
2022
Q3 | $28.8M | Buy |
1,336,368
+10,000
| +0.8% | +$215K | 5.06% | 7 |
|
|
2022
Q2 | $26.2M | Sell |
1,326,368
-622,416
| -32% | -$12.3M | 5.99% | 7 |
|
|
2022
Q1 | $45.8M | Buy |
1,948,784
+635,177
| +48% | +$14.9M | 10.83% | 1 |
|
|
2021
Q4 | $35.8M | Hold |
1,313,607
| – | – | 11.8% | 2 |
|
|
2021
Q3 | $36.2M | Buy |
1,313,607
+29,720
| +2% | +$818K | 13.16% | 1 |
|
|
2021
Q2 | $36.5M | Buy |
1,283,887
+322,090
| +33% | +$9.17M | 15.02% | 1 |
|
|
2021
Q1 | $32.8M | Hold |
961,797
| – | – | 13.81% | 1 |
|
|
2020
Q4 | $32M | Sell |
961,797
-95,000
| -9% | -$3.16M | 11.45% | 1 |
|
|
2020
Q3 | $34M | Buy |
1,056,797
+46,000
| +5% | +$1.48M | 14.39% | 1 |
|
|
2020
Q2 | $27.8M | Sell |
1,010,797
-10,000
| -1% | -$275K | 12.42% | 2 |
|
|
2020
Q1 | $16.4M | Buy |
1,020,797
+31,798
| +3% | +$510K | 9.92% | 3 |
|
|
2019
Q4 | $23.6M | Buy |
+988,999
| New | +$23.6M | 14.31% | 2 |
|